Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- CRNC +4%
Other news:
- PERF +20% (announces commencement of self tender offer to purchase up to 16,129,032 class a ordinary shares for an aggregate purchase price of up to $50 mln)
- ABEO +5.3% (receives FDA acceptance and grants Priority Review for Pz-cel BLA)
- THRX +5.2% (confirms receipt of Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and unsolicited proposal from Concentra Biosciences LLC)
- SHOP +4.1% (announces a Black Friday record with a combined $4.1 billion in sales from businesses worldwide)
- ARMN +3.8% (increases Segovia gold mineral reserves by +75% to 1.3 moz and announces plant expansion to increase production rate)
- ATEX +2.9% (signed an agreement providing TECO the use of Anterix's 900 MHz spectrum throughout the company's service territory in West Central Florida)
- FREY +1.2% (announces new organizational structure and leadership changes)
- SNY +1.1% (Regeneron Pharma and Sanofi (SNY) reports Dupixent significantly reduced COPD Exacerbations in Second Positive Phase 3 Trial, Accelerating FDA Submission and Confirming Potential to Become First Approved Biologic for This Serious Disease)
- REGN +0.8% (Regeneron Pharma and Sanofi (SNY) reports Dupixent significantly reduced COPD Exacerbations in Second Positive Phase 3 Trial, Accelerating FDA Submission and Confirming Potential to Become First Approved Biologic for This Serious Disease)
Analyst comments:
- CCL +1% (upgraded to Buy from Hold at Melius Research)